Back to Search
JOHN SEFTON, DO
DO
Family Medicine Physician
NPI: 1679559470IndividualAccepts Medicare
Specialties, Licenses & Credentials
Family Medicine PhysicianPrimary
Family Medicine
Code: 207Q00000X
34004130(OH)
CMS Specialties
PrimaryFAMILY PRACTICE
Education
OHIO UNIVERSITY, COLLEGE OF OSTEOPATHIC MEDICINE
Class of 1985
Research & Publications (14)
Photodamage pilot study: a double-blind, vehicle-controlled study to assess the efficacy and safety of tazarotene 0.1% gel.
PMID 11004622·J Am Acad Dermatol·2000
3-trial
Cryotherapy and ankle bracing effects on peroneus longus response during sudden inversion.
PMID 19427798·J Electromyogr Kinesiol·2010
8-other
Sensorimotor function as a predictor of chronic ankle instability.
PMID 19346037·Clin Biomech (Bristol)·2009
8-other
Segmental spinal reflex adaptations associated with chronic ankle instability.
PMID 18929028·Arch Phys Med Rehabil·2008
8-other
Effect of inversion and ankle bracing on peroneus longus Hoffmann reflex.
PMID 17076833·Scand J Med Sci Sports·2007
8-other
A multicenter, randomized, double-blind trial of tazarotene 0.1% cream in the treatment of photodamage.
PMID 15692472·J Am Acad Dermatol·2005
3-trial
Effects of tazarotene 0.1 % cream in the treatment of facial acne vulgaris: pooled results from two multicenter, double-blind, randomized, vehicle-controlled, parallel-group trials.
PMID 15639698·Clin Ther·2004
4-observational
Histological effects of tazarotene 0.1% cream vs. vehicle on photodamaged skin: a 6-month, multicentre, double-blind, randomized, vehicle-controlled study in patients with photodamaged facial skin.
PMID 15606521·Br J Dermatol·2004
3-trial
Pharmacokinetics of tazarotene cream 0.1% after a single dose and after repeat topical applications at clinical or exaggerated application rates in patients with acne vulgaris or photodamaged skin.
PMID 12885265·Clin Pharmacokinet·2003
3-trial
Tazarotene cream in the treatment of psoriasis: Two multicenter, double-blind, randomized, vehicle-controlled studies of the safety and efficacy of tazarotene creams 0.05% and 0.1% applied once daily for 12 weeks.
PMID 12734506·J Am Acad Dermatol·2003
3-trial
Efficacy of 0.1% tazarotene cream for the treatment of photodamage: a 12-month multicenter, randomized trial.
PMID 12437455·Arch Dermatol·2002
3-trial
Tazarotene cream for the treatment of facial photodamage: a multicenter, investigator-masked, randomized, vehicle-controlled, parallel comparison of 0.01%, 0.025%, 0.05%, and 0.1% tazarotene creams with 0.05% tretinoin emollient cream applied once daily for 24 weeks.
PMID 11735710·Arch Dermatol·2001
3-trial
A pilot study to determine the effect of tazarotene gel 0.1% on steroid-induced epidermal atrophy.
PMID 11679006·Int J Dermatol·2001
3-trial
Tazarotene plus UVB phototherapy in the treatment of psoriasis.
PMID 11050587·J Am Acad Dermatol·2000
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 2510 COMMONS BLVD, SUITE 110
BEAVERCREEK, OH 45431 - Phone
- (937) 490-0123
Quick Facts
- NPI
- 1679559470
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 41
- Publications
- 14
Are you this provider?
Claim Your Profile